Obdulia Rabal, Group Leader Computational Chemist at Evotec

Obdulia Rabal

Group Leader Computational Chemist at Evotec | Toulouse, Occitanie, France

Profile last verified August 2026
Pharmaceuticals Verified Profile Toulouse, Occitanie, France Universitat de Barcelona
Verified

Work Email

***@evotec.com

Last verified May 2026

Personal Email

***@gmail.com

Personal • High Confidence

Phone Number

+34*****

France • Mobile

Free account · No credit card · 5 profiles/month

Obdulia Rabal Socials
Obdulia Rabal Work Experience

Group Leader Computational Chemist at Evotec in April 2023 - Present

Innovation Manager at Pharmacelera in October 2021 - April 2023

Senior Computational Chemist at Evotec in July 2019 - October 2021

See more See less

Staff Scientist - Computational Chemistry at CIMA - Center for Applied Medical Research. University of Navarra in March 2011 - July 2019

Staff Scientist - Computational Chemistry at CNIO in January 2007 - March 2011

Technician. Quality Department. at Nestlé in July 2001 - September 2001

Student. R+D. Aiscondel Aragonesas at Ercros in June 1999 - August 1999

Obdulia Rabal Education

Universitat de Barcelona, Degree in Biochemistry, September 2026

IQS Barcelona, PhD, September 2026

IQS Barcelona, September 1996 to September 2026

See more See less

EOI Business School, September 2026

Obdulia Rabal Skills
drug discovery Pipeline Pilot Cheminformatics virtual screening Patents medicinal chemistry Database Design Bioinformática Chemistry Biochemistry
About Obdulia Rabal’s Current Company
Evotec

Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients. Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing. We aspire to contribute data-driven disease understanding and early disease relevance in humans to bring the probability of success up. We select the right modality, which is then propelled forward on our platforms by our passionate people striving for the fastest and most effective ways towards patient impact. This is enabled by convergence of human ingenuity with data and AI. We also offer specific solutions, products, and CRO/CDMO-like services, always in support of the Biopharma R&D innovator. Our more than 4,000 scientists work closely with numerous partners concurrently, delivering fully integrated research and development portfolios or individual projects with the highest quality standards and efficiency, coupled with great science, passion, engagement, and communication.

Discover more about Evotec
Obdulia Rabal’s Colleagues
Christian Wojczewski

Christian Wojczewski

Hamburg, Hamburg, Germany

Experienced CEO and advisor of Healthcare companies

CEO at Evotec
(July 2024 – Present)

Jakob Freitag

Jakob Freitag

Berlin, Berlin, Germany

Integration First

Owner at evolution|one
(October 1999 – Present)

Giuseppina Claps

Giuseppina Claps

Toulouse, Occitanie, France

Research Scientist - Team Leader - preclinical in vivo pharmacology

Research Scientist - Team Leader - preclinical in vivo pharmacology at Evotec
(February 2021 – Present)

Francois Autelitano

Francois Autelitano

Toulouse, Occitanie, France

Vice-President, Head of Translational Proteomics & Metabolomics - Modality Lead for Covalent Drugs - Evotec France

Vice-President, Head of Translational Proteomics & Metabolomics at Evotec
(April 2020 – Present)

Gillesolivier Gratien

Gillesolivier Gratien

Toulouse, Occitanie, France

Research Scientist | Team Leader in Medicinal Chemistry at Evotec

Research Scientist | Team Leader in Synthetic and Medicinal Chemistry at Evotec
(November 2023 – Present)

Justyna Wojnopicon

Justyna Wojnopicon

Toulouse, Occitanie, France

Drug Discovery Project Leader at Evotec/ Medicinal Chemist

Integrated Drug Discovery Project Leader, GL Medicinal Chemistry at Evotec
(August 2022 – Present)

Search similar profiles
Frequently asked questions about Obdulia Rabal

What is Obdulia Rabal email address?

Email Obdulia Rabal at [email protected] and [email protected]. This email is the most updated Obdulia Rabal's email found in 2026.

What is Obdulia Rabal phone number?

Obdulia Rabal phone number is +34626767615.

How to contact Obdulia Rabal?

To contact Obdulia Rabal send an email to [email protected] or [email protected]. If you want to call Obdulia Rabal try calling on +34626767615. (updated on November 17, 2025)

What company does Obdulia Rabal work for?

Obdulia Rabal works for Evotec.

What is Obdulia Rabal's role at Evotec?

Obdulia Rabal is Group Leader Computational Chemist

What industry does Obdulia Rabal work in?

Obdulia Rabal works in the Pharmaceuticals industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free